Andrew J. Last - Jun 23, 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew J. Last
Stock symbol
OCX
Transactions as of
Jun 23, 2023
Transactions value $
$0
Form type
4
Date filed
6/27/2023, 09:30 PM
Previous filing
May 1, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +20K +28.5% $0.00 90.2K Jun 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +90K $0.00 90K Jun 23, 2023 Common Stock 90K $0.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
F2 Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.